Silver sulfadiazine nanosystems for burn therapy

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 254-264

  Venkataraman, Meenakshi ^a   Nagarsenker, Mangal ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

antibacterial study; burn; high pressure homogenization; nanosuspension; silver sulfadiazine

Indexed keywords

CARBOPOL 974P; CREMOPHOR; NANOMATERIAL; SULFADIAZINE SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; BURN; CONTROLLED STUDY; CREAM; DIALYSIS MEMBRANE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; ESCHERICHIA COLI; FEMALE; GEL; IN VITRO STUDY; IN VIVO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; STAPHYLOCOCCUS AUREUS; SUSPENSION; TOPICAL TREATMENT; TRANSMISSION ELECTRON MICROSCOPY; WOUND CONTRACTION; WOUND HEALING; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

ANTI-BACTERIAL AGENTS; BURNS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SILVER SULFADIAZINE; X-RAY DIFFRACTION;

EID: 84878610858     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9914-0     Document Type: Article

References (32)

1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403-34.
2. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007;33:139-48.
3. Fox CL, Modak SM. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother. 1974;5:582-8.
4. Maple PAC, Hamilton-Miller JMT, Brranfltt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic and, nitroforazone, silver sulphadiazine and mupirocin against methcillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1992;29:661-8.
5. Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147-79.
6. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76-83.
7. Bult A. Silver sulfadiazine and related antibacterial metal sulfanilamides: facts and fancy. Pharm Int. 1982;3:400-4.
8. Capelli CC, Wis K, inventor; Biointerface Technologies, Inc., Madison, Wis, assignee. Metal Based antimicrobial coating. United States Patent 4933178.1990 June 12.
9. Dollery C. Silver sulfadiazine. In: Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999. p. S32-5.
10. Strydom SJ, Rose WE, Otto DP, Liebenberg W, de Villers MM. Poly (amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine. 2012. doi: 10.1016/j.nano.2012.03.006.
11. Mishra PR, Shaal LA, Müller RH, Keck CM. Production and characterization of hersperetin nanosuspensions for dermal delivery. Int J Pharm. 2009;371:182-9.
12. Kipp JE, Wong JCT, Doty MJ, Rebbeck CL, inventor; Baxter International Inc., assignee. Microprecipitation method for preparing submicron suspensions. US Patent 6869617 B2. 2005 Mar 22.
13. Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, et al. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Int J Pharm. 2009;379:167-73.
14. Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanoparticles Res. 2008;10:845-62.
15. Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40:325-34.
16. Lindfors L, Skantze P, Skantze U, Rasmusson M, Zackrisson A, Olsson U. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. Langmuir. 2006;22:906-10.
17. Sigfridsson K, Forssen S, Hollander P, Skantze U, de Verdier J. A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound. Eur J Pharm Biopharm. 2007;67:540-7.
18. Carr HS, Wlodkowski TJ, Rosenkranz HS. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother. 1973;4:585-7.
19. Hamilton-Miller JMT, Shah S. A microbiological assessment of silver fusidate, a novel topical antimicrobial agent. Int J Antimicrob Agents. 1996;7:97-9.
20. Waasbergen LG, Fajdetic I, Fianchini M, Dias HVR. Antimicrobial properties of highly fluorinated tris(pyrazolyl)borates. J Inorg Biochem. 2007;101:1180-3.
21. Verger MLL, Fluckiger L, Kim Y, Hoffman M, Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm. 1998;46:137-43.
22. Nascimento EG, Sampaio TB, Medeiros AC, Azevedo EP. Evaluation of chitosan gel with 1% silver sulfadiazine as an alternative for burn wound treatment in rats. Acta Cir Bras. 2009;24:460-5.
23. Alemdaroglu C, Degim Z, Celebi N, Zor F, Ozturk S, Erdogan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns. 2006;32:319-27.
24. Srivastava P, Durgaprasad S. Burn wound healing property of Cocos nucifera: an appraisal. Indian J Pharmacol. 2008;40:144-6.
25. Krause KP, Müller RH. Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation. Int J Pharm. 2001;214:21-4.
26. Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62:3-16.
27. Bult A, Plug CM. Silver sulfadiazine. In: Florey K, editor. Analytical profile of drug substances. New York: Academic; 1984. p. 553-71.
28. Ginalska G, Osinska M, Uryniak A, Urbanik-Sypniewska T, Belcarz A, Rzeski W, et al. Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur J Vasc Endovasc Surg. 2005;29:419-24.
29. Thirumurugan G, Shaheedha SM, Dhanaraju MD. In-vitro evaluation of anti-bacterial activity of silver nanoparticles synthesised by using Phytophthora infestans. Int J ChemTech Res. 2009;1:714-6.
30. Panáek A, Kvítek L, Prucek R, Kolář M, Veeřová R, Pizúrová N, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110:16248-53.
31. Mi FL, Wu YB, Shyu SS, Chao AC, Lai JY, Su CC. Asymmetric chitosan membranes prepared by dry/wet phase separation: a new type of wound dressing for controlled antibacterial release. J Membr Sci. 2003;212:237-54.
32. Tas C, Ozkan Y, Savaser A, Baykara T. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. II Farmaco. 2003;58:605-11.